Tag: India Ratings and Research

Health

Ind-Ra, Well being Information, ET HealthWorld

Mumbai: India Ratings and Research (Ind-Ra) has mentioned that the 51.5 p.c year-on-year progress in India's pharmaceutical market throughout April was led by a low base impact because the market declined by 10.2 p.c in April 2020 on account of Covid-19 lockdown.The expansion would have been stronger on an adjusted foundation, it mentioned. Acute therapies like anti-infective and vitamins benefitted considerably as a result of second Covid wave as these therapies have a direct and oblique position in treatment of patients.The acute remedy progress was additionally aided by low base in April final yr, mentioned Ind-Ra.Throughout April 2021, volumes grew 34.5 p.c YoY, worth progress was 7 per cent and product launches have been at 10 per cent attributed to acute therapy products. Ind-Ra esti...
Business

Report, Well being Information, ET HealthWorld

NEW DELHI: The well being insurance section, which has seen robust progress over the past 5 years, will proceed to witness the next double-digit progress within the medium time period helped by low penetration, in response to a report.Throughout FY15-FY20, the section expanded by a compound annual progress fee (CAGR) of 20 per cent.“We count on the sector to develop at greater double digits within the medium time period, with non-public players rising even quicker as they've been gaining market share over public sector companies and in addition due to the rise in premium costs on account of medical inflation,” India Ratings and Research mentioned in a report.The company mentioned it's important for insurers to keep up satisfactory buffers over the regulatory minimal in order to be ready fo...
Business

Ind-Ra, Well being Information, ET HealthWorld

Mumbai: The cost of vaccinating the complete inhabitants above 18 years of age can be solely 0.36 % of the gross domestic product (GDP), based on India Ratings and Research (Ind-Ra).Because the second wave of Covid-19 sweeps the nation with alarming pace and severity, the Central authorities has introduced a liberalised and accelerated part three technique of vaccination.Underneath this scheme, all individuals above 18 years of age can be eligible to get Covid-19 vaccine doses from May 1. Which means that the overall measurement of the inhabitants that can now be eligible for vaccination can be 84.2 crore out of the overall inhabitants of 133.3 crore.Ind-Ra mentioned this may increasingly value Rs 67,193 crore of which the Central authorities will incur Rs 20,870 crore and state government...